How blood transfusions affect stress markers in newborns
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at how blood transfusions change stress-related substances in the blood of newborns. It might help doctors understand how transfusions affect babies in the NICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is in the neonatal intensive care unit (NICU) after birth.
- Parents or guardians have signed a consent form allowing participation.
- Baby is a newborn (up to 48 hours old when admitted for part B).
- Baby does not have major birth defects or inherited blood disorders like sickle cell disease.
- Baby did not receive a blood transfusion before birth.
- Parents and doctors are committed to full life support for the baby.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a simple non-invasive score that uses blood flow in muscles to predict if a newborn has or will develop high inflammation levels (C-reactive protein). It may help doctors start treatment earlier in babies with breathing problems.
This trial tests whether red blood cells made from donated cord blood are safe and effective for transfusions in extremely premature infants. It aims to see if this alternative blood source can help babies born before 28 weeks or weighing less than 1000 grams.
This trial looks at whether red blood cell transfusions are linked to health problems in very premature babies. It may help doctors better understand how to care for these infants.
This trial tests whether using specially prepared blood from umbilical cords (enriched with fetal hemoglobin) works better for premature babies who need blood transfusions. The goal is to see if this approach reduces complications and the number of transfusions needed during hospitalization.
This study uses a light-based sensor placed on the skin to measure oxygen levels in the gut area of preterm babies during a blood transfusion. It aims to see if this method can safely monitor how well your baby is tolerating the transfusion.
This study looks at two substances in the blood from the umbilical cord (IL-6 and lactate) to see if they can help doctors understand how well a newborn is doing after birth.
Hear when a new Near Infrared Spectroscopy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.